Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 5S ribosomal pseudogene 40 (RNA5SP40) is a pseudogene related to ribosomal 5S RNA, classified as a non-coding RNA gene that has lost its ability to code for a functional product[2][5][6]. Pseudogenes like RNA5SP40 often arise by gene duplication or retrotransposition, but accumulate disabling mutations over evolutionary time and are considered non-functional "genomic fossils" or "junk DNA"[8]. In some cases, pseudogenes are transcribed, and a subset may participate in regulatory processes such as acting as competing endogenous RNAs or lncRNAs, but for most ribosomal RNA pseudogenes—including RNA5SP40—such functions are generally unproven or absent[3][7]. While global pseudogene expression patterns are increasingly studied for potential utility in cancer subtyping or prognosis, there is no evidence that RNA5SP40 itself is a disease driver, drug target, or biomarker[7]. It is neither a therapeutic target (such as receptor, enzyme, ion channel, or transporter), nor a functional protein-coding gene[2][5][6][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 5S ribosomal pseudogene 40 (RNA5SP40).